The FOXO4‑DRI peptide is revolutionizing cellular senescence therapy by selectively clearing harmful “zombie cells” to combat aging and promote healthier, longer lives. This breakthrough offers exciting hope for tackling age-related diseases at their root.
More-
July 22, 2025
FOXO4-DRI Peptide: Cellular Senescence Research Explained
-
July 22, 2025
Senolytic Peptides Research: Longevity Science Explained (58 chars)
Senolytic peptides are at the forefront of anti-aging research, offering an exciting approach to improve longevity by targeting and eliminating harmful senescent cells that contribute to aging and disease. Discover how these innovative compounds could revolutionize the way we age and support healthier, longer lives.
More